Pilot study of levodopa dose as treatment for residual amblyopia in children aged 8 years to younger than 18 years.
Repka MX, Kraker RT, Beck RW, Atkinson CS, Bacal DA, Bremer DL, Davis PL, Gearinger MD, Glaser SR, Hoover DL, Laby DM, Morrison DG, Rogers DL, Sala NA, Suh DW, Wheeler MB; Pediatric Eye Disease Investigator Group.
Repka MX, et al. Among authors: morrison dg.
Arch Ophthalmol. 2010 Sep;128(9):1215-7. doi: 10.1001/archophthalmol.2010.178.
Arch Ophthalmol. 2010.
PMID: 20837811
Free PMC article.
Clinical Trial.
No abstract available.